146 related articles for article (PubMed ID: 9786607)
1. Comparison between cilnidipine and nisoldipine with respect to effects on blood pressure and heart rate in hypertensive patients.
Minami J; Ishimitsu T; Higashi T; Numabe A; Matsuoka H
Hypertens Res; 1998 Sep; 21(3):215-9. PubMed ID: 9786607
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 24-hour blood pressure, heart rate, and autonomic nerve activity in hypertensive patients treated with cilnidipine or nifedipine retard.
Minami J; Ishimitsu T; Kawano Y; Numabe A; Matsuoka H
J Cardiovasc Pharmacol; 1998 Aug; 32(2):331-6. PubMed ID: 9700998
[TBL] [Abstract][Full Text] [Related]
3. Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.
Minami J; Kawano Y; Makino Y; Matsuoka H; Takishita S
Br J Clin Pharmacol; 2000 Dec; 50(6):615-20. PubMed ID: 11136301
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate.
White WB; Mansoor GA; Pickering TG; Vidt DG; Hutchinson HG; Johnson RB; Noveck R
Am J Hypertens; 1999 Aug; 12(8 Pt 1):806-14. PubMed ID: 10480474
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory blood pressure monitoring in patients with essential hypertension treated with a new calcium antagonist, cilnidipine.
Tominaga M; Ohya Y; Tsukashima A; Kobayashi K; Takata Y; Koga T; Yamashita Y; Fujishima Y; Abe I; Fujishima M
Cardiovasc Drugs Ther; 1997 Mar; 11(1):43-8. PubMed ID: 9140677
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of cilnidipine and amlodipine on ambulatory blood pressure.
Hoshide S; Kario K; Ishikawa J; Eguchi K; Shimada K
Hypertens Res; 2005 Dec; 28(12):1003-8. PubMed ID: 16671340
[TBL] [Abstract][Full Text] [Related]
8. Effect of morning and bedtime dosing with cilnidipine on blood pressure, heart rate, and sympathetic nervous activity in essential hypertensive patients.
Kitahara Y; Saito F; Akao M; Fujita H; Takahashi A; Taguchi H; Hino T; Otsuka Y; Kushiro T; Kanmatsuse K
J Cardiovasc Pharmacol; 2004 Jan; 43(1):68-73. PubMed ID: 14668570
[TBL] [Abstract][Full Text] [Related]
9. The effects of the L/N-type calcium channel blocker (cilnidipine) on sympathetic hyperactive morning hypertension: results from ACHIEVE-ONE.
Kario K; Ando S; Kido H; Nariyama J; Takiuchi S; Yagi T; Shimizu T; Eguchi K; Ohno M; Kinoshita O; Yamada T
J Clin Hypertens (Greenwich); 2013 Feb; 15(2):133-42. PubMed ID: 23339732
[TBL] [Abstract][Full Text] [Related]
10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
Shimada K; Ogihara T; Saruta T; Kuramoto K;
Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the anti-hypertensive effects of the L/N-type calcium channel antagonist cilnidipine, and the L-type calcium channel antagonist amlodipine in hypertensive patients with cerebrovascular disease.
Takei K; Araki N; Ohkubo T; Tamura N; Yamamoto T; Furuya D; Yanagisawa CT; Shimazu K
Intern Med; 2009; 48(16):1357-61. PubMed ID: 19687579
[TBL] [Abstract][Full Text] [Related]
12. L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
Kanaoka T; Tamura K; Wakui H; Ohsawa M; Azushima K; Uneda K; Kobayashi R; Fujikawa T; Tsurumi-Ikeya Y; Maeda A; Yanagi M; Toya Y; Umemura S
Int J Mol Sci; 2013 Aug; 14(8):16866-81. PubMed ID: 23959116
[TBL] [Abstract][Full Text] [Related]
13. Reduction of white coat effect by cilnidipine in essential hypertension.
Morimoto S; Takeda K; Oguni A; Kido H; Harada S; Moriguchi J; Itoh H; Nakata T; Sasaki S; Nakagawa M
Am J Hypertens; 2001 Oct; 14(10):1053-7. PubMed ID: 11710785
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 24-hour blood pressure profiles in patients with hypertension who were switched from amlodipine to nisoldipine.
Lenz TL; Wurdeman RL; Hilleman DE
Pharmacotherapy; 2001 Aug; 21(8):898-903. PubMed ID: 11718496
[TBL] [Abstract][Full Text] [Related]
15. Effects of a dual L/N-type calcium channel blocker cilnidipine on blood pressure, pulse rate, and autonomic functions in patients with mild to moderate hypertension.
Kai T; Kuzumoto Y
Clin Exp Hypertens; 2009 Oct; 31(7):595-604. PubMed ID: 19886857
[TBL] [Abstract][Full Text] [Related]
16. Renoprotective and antioxidant effects of cilnidipine in hypertensive patients.
Soeki T; Kitani M; Kusunose K; Yagi S; Taketani Y; Koshiba K; Wakatsuki T; Orino S; Kawano K; Sata M
Hypertens Res; 2012 Nov; 35(11):1058-62. PubMed ID: 22763473
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic agents in the management of hypertension--nisoldipine coat-core.
White WB
J Clin Hypertens (Greenwich); 2007 Apr; 9(4):259-66. PubMed ID: 17396068
[TBL] [Abstract][Full Text] [Related]
18. Calcium channel blockers shorten the periodicity of ultradian variation in blood pressure in patients with essential hypertension.
Kawamura H; Mitsubayashi H; Saito T; Kanmatsuse K; Saito N
Hypertens Res; 1998 Sep; 21(3):179-86. PubMed ID: 9786602
[TBL] [Abstract][Full Text] [Related]
19. Effect of cilnidipine on left ventricular diastolic function in hypertensive patients as assessed by pulsed Doppler echocardiography and pulsed tissue Doppler imaging.
Onose Y; Oki T; Yamada H; Manabe K; Kageji Y; Matsuoka M; Yamamoto T; Tabata T; Wakatsuki T; Ito S
Jpn Circ J; 2001 Apr; 65(4):305-9. PubMed ID: 11316128
[TBL] [Abstract][Full Text] [Related]
20. Nisoldipine coat-core and heart rate response during treatment of hypertension.
Zannad F
Int J Clin Pract; 1999; 53(1):65-71. PubMed ID: 10344070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
